Evidence map›Paper›PMID 29563837›Full record

ArticleClinical epidemiology2018

Combining statistical techniques to predict postsurgical risk of 1-year mortality for patients with colon cancer.

Inmaculada Arostegui, Nerea Gonzalez, Nerea Fernández-de-Larrea, Santiago Lázaro-Aramburu, Marisa Baré, Maximino Redondo, Cristina Sarasqueta, Susana Garcia-Gutierrez, José M Quintana, REDISSEC CARESS-CCR Group

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02488161 (Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02488161 completednot on this map

Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study

TypeobservationalSponsorHospital Galdakao-UsansoloRan2010 to 2015Enrolled2,600ConditionsColorectal CancerArmsNo intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Inmaculada ArosteguiDepartment of Applied Mathematics, Statistics and Operations Research, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain.
Nerea GonzalezHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
Nerea Fernández-de-LarreaEnvironmental and Cancer Epidemiology Unit, National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Santiago Lázaro-AramburuGeneral Surgery Service, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain.
Marisa BaréHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
Maximino RedondoHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
Cristina SarasquetaHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
Susana Garcia-GutierrezHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
José M QuintanaHealth Services Research on Chronic Patients Network (REDISSEC), Galdakao, Bizkaia, Spain.
REDISSEC CARESS-CCR Group
Hospital de Galdakao · ESBiogipuzkoa Health Research Institute · ESHospital Costa del Sol · ESInstituto de Salud Carlos III · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer is one of the most frequently diagnosed malignancies and a common cause of cancer-related mortality. The aim of this study was to develop and validate a clinical predictive model for 1-year mortality among patients with colon cancer who survive for at least 30 days after surgery.

methodsPatients diagnosed with colon cancer who had surgery for the first time and who survived 30 days after the surgery were selected prospectively. The outcome was mortality within 1 year. Random forest, genetic algorithms and classification and regression trees were combined in order to identify the variables and partition points that optimally classify patients by risk of mortality. The resulting decision tree was categorized into four risk categories. Split-sample and bootstrap validation were performed. ClinicalTrials.gov Identifier: NCT02488161.

resultsA total of 1945 patients were enrolled in the study. The variables identified as the main predictors of 1-year mortality were presence of residual tumor, American Society of Anesthesiologists Physical Status Classification System risk score, pathologic tumor staging, Charlson Comorbidity Index, intraoperative complications, adjuvant chemotherapy and recurrence of tumor. The model was internally validated; area under the receiver operating characteristic curve (AUC) was 0.896 in the derivation sample and 0.835 in the validation sample. Risk categorization leads to AUC values of 0.875 and 0.832 in the derivation and validation samples, respectively. Optimal cut-off point of estimated risk had a sensitivity of 0.889 and a specificity of 0.758.

conclusionThe decision tree was a simple, interpretable, valid and accurate prediction rule of 1-year mortality among colon cancer patients who survived for at least 30 days after surgery.

Indexed as

1-year-mortalityclinical prediction rulescolonic neoplasmscolorectal surgeryprediction modeltree-based methods

Identifiers

PMID29563837
PMCPMC5846756
OpenAlexW2790094050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.